Regenerative Medical Technology Group (RMTG) Stock Overview
Regenerative Medical Technology Group Inc. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
RMTG Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Regenerative Medical Technology Group Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.037 |
| 52 Week High | US$0.079 |
| 52 Week Low | US$0.019 |
| Beta | 1.18 |
| 1 Month Change | 17.29% |
| 3 Month Change | 47.32% |
| 1 Year Change | 3.46% |
| 3 Year Change | 111.06% |
| 5 Year Change | -72.51% |
| Change since IPO | -99.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| RMTG | US Specialty Retail | US Market | |
|---|---|---|---|
| 7D | 67.4% | -1.7% | 0.7% |
| 1Y | 3.5% | 2.1% | 20.6% |
Return vs Industry: RMTG exceeded the US Specialty Retail industry which returned 0.6% over the past year.
Return vs Market: RMTG underperformed the US Market which returned 19.5% over the past year.
Price Volatility
| RMTG volatility | |
|---|---|
| RMTG Average Weekly Movement | 68.0% |
| Specialty Retail Industry Average Movement | 7.5% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: RMTG's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: RMTG's weekly volatility has increased from 51% to 68% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | n/a | Dave Christensen | regenmedtechgroup.com |
Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equipment, and services.
Regenerative Medical Technology Group Inc. Fundamentals Summary
| RMTG fundamental statistics | |
|---|---|
| Market cap | US$466.43k |
| Earnings (TTM) | -US$7.93m |
| Revenue (TTM) | US$6.38m |
Is RMTG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RMTG income statement (TTM) | |
|---|---|
| Revenue | US$6.38m |
| Cost of Revenue | US$2.74m |
| Gross Profit | US$3.63m |
| Other Expenses | US$11.56m |
| Earnings | -US$7.93m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.60 |
| Gross Margin | 56.99% |
| Net Profit Margin | -124.36% |
| Debt/Equity Ratio | -56.1% |
How did RMTG perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/10 08:08 |
| End of Day Share Price | 2026/07/10 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Regenerative Medical Technology Group Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.